Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Amos Katz, Theodore P. Abraham et al.|The Lancet|2020

Cited by 1.2k